ID

26665

Description

Study ID: 100690 Clinical Study ID: NKP100690 Study Title: A randomised, double blind triple dummy, placebo controlled balanced incomplete block crossover study to evaluate the change in response to a 7% CO2 challenge and pharmacokinetics of single oral doses of GW597599 and paroxetine (5 or 7.5 mg) either alone or in combination, or alprazolam (0.75 mg) in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: paroxetine Trade Name: Tagonis,Seroxat,Paxil,Paroxat,Deroxat,Aropax Study Indication: Depressive Disorder and Anxiety Disorders CRF Seiten: 255-365

Keywords

Versions (1)
  1. 10/23/17 10/23/17 -
Copyright Holder

GSK

Uploaded on

October 23, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

7% CO2, GW597599, paroxetine andor alprazolam in healthy volunteers 100690

English

Adverse Event

1 forms  
  1. StudyEvent: ODM
    1. Adverse Event
Please note any SERIOUS events should not be recorded on this page, but on the Serious Adverse Event pages provided. Record any Adverse event (using standard medical terminology) observed or elicited by the following direct question to the subject: "Do you feel different in any way since starting the treatment or since the last visit?" Provide the diagnosis not symptoms where possible. (One adverse event per column) If no adverse events, please mark box D and sign form below
Description

Please note any SERIOUS events should not be recorded on this page, but on the Serious Adverse Event pages provided. Record any Adverse event (using standard medical terminology) observed or elicited by the following direct question to the subject: "Do you feel different in any way since starting the treatment or since the last visit?" Provide the diagnosis not symptoms where possible. (One adverse event per column) If no adverse events, please mark box D and sign form below

Alias
UMLS CUI-1
C0877248
Adverse Event
Description

Adverse Event

Data type

text

Alias
UMLS CUI [1]
C0877248
GSK Use
Description

Investigator Use

Data type

text

Alias
UMLS CUI [1,1]
C0008961
UMLS CUI [1,2]
C0457083
Onset Date/Time
Description

Onset Date/Time

Data type

datetime

Alias
UMLS CUI [1]
C2826806
End Date/Time
Description

End Date/Time

Data type

datetime

Alias
UMLS CUI [1]
C2826793
Outcome
Description

Outcome

Data type

text

Alias
UMLS CUI [1]
C1705586
Event Course
Description

Event Course

Data type

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0750729
Intensity (Maximum)
Description

Intensity

Data type

text

Alias
UMLS CUI [1]
C1710066
Action Taken with Respect to lnvestigational Drug
Description

Drug Action Taken

Data type

text

Alias
UMLS CUI [1,1]
C2826626
UMLS CUI [1,2]
C0304229
Relationship to lnvestigational Drug
Description

Relationship to lnvestigational Drug

Data type

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0304229
Corrective Therapy. If "Yes", Please record on Concomitant Medication form
Description

Corrective Therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
Was subject withdrawn due to this AE?
Description

Study withdrawal

Data type

boolean

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0877248
Administrative Documentation
Description

Administrative Documentation

Alias
UMLS CUI-1
C1320722
Subject Number
Description

Subject Number

Data type

text

Alias
UMLS CUI [1]
C2348585
Investigator's Signature:
Description

Investigators Signature

Data type

text

Alias
UMLS CUI [1]
C2346576
Date
Description

Investigator Signature Date

Data type

date

Alias
UMLS CUI [1,1]
C0807937
UMLS CUI [1,2]
C2346576
Back to the top of the page

Similar models

Adverse Event

1 forms
  1. StudyEvent: ODM
    1. Adverse Event
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Please note any SERIOUS events should not be recorded on this page, but on the Serious Adverse Event pages provided. Record any Adverse event (using standard medical terminology) observed or elicited by the following direct question to the subject: "Do you feel different in any way since starting the treatment or since the last visit?" Provide the diagnosis not symptoms where possible. (One adverse event per column) If no adverse events, please mark box D and sign form below
C0877248 (UMLS CUI-1)
Adverse Event
Item
Adverse Event
text
C0877248 (UMLS CUI [1])
Investigator Use
Item
GSK Use
text
C0008961 (UMLS CUI [1,1])
C0457083 (UMLS CUI [1,2])
Onset Date/Time
Item
Onset Date/Time
datetime
C2826806 (UMLS CUI [1])
End Date/Time
Item
End Date/Time
datetime
C2826793 (UMLS CUI [1])
Item
Outcome
text
C1705586 (UMLS CUI [1])
Outcome
Code List
Outcome
CL Item
Resolved (Resolved)
CL Item
Ongoing (Ongoing)
Item
Event Course
text
C0877248 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
Event Course
Code List
Event Course
CL Item
Intermittent (Number of Episodes) (Intermittent (Number of Episodes))
CL Item
Constant (Constant)
Item
Intensity (Maximum)
text
C1710066 (UMLS CUI [1])
Intensity
Code List
Intensity (Maximum)
CL Item
Mild (Mild)
CL Item
Moderate (Moderate)
CL Item
Severe (Severe)
Item
Action Taken with Respect to lnvestigational Drug
text
C2826626 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Drug Action Taken
Code List
Action Taken with Respect to lnvestigational Drug
CL Item
None (None)
CL Item
Dose Reduced (Dose Reduced)
CL Item
Dose increased (Dose increased)
CL Item
Dose interrupted/restarted (Dose interrupted/restarted)
CL Item
Drug stopped (Drug stopped)
Item
Relationship to lnvestigational Drug
text
C0877248 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
Relationship to lnvestigational Drug
Code List
Relationship to lnvestigational Drug
CL Item
Not related (Not related)
CL Item
Unlikely (Unlikely)
CL Item
Suspected (Reasonable possibility) (Suspected (Reasonable possibility))
CL Item
Probable (Probable)
Corrective Therapy
Item
Corrective Therapy. If "Yes", Please record on Concomitant Medication form
boolean
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Study withdrawal
Item
Was subject withdrawn due to this AE?
boolean
C0422727 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Item Group
C1320722 (UMLS CUI-1)
Subject Number
Item
Subject Number
text
C2348585 (UMLS CUI [1])
Investigators Signature
Item
Investigator's Signature:
text
C2346576 (UMLS CUI [1])
Investigator Signature Date
Item
Date
date
C0807937 (UMLS CUI [1,1])
C2346576 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial